Care for children with atopic dermatitis in the Netherlands during the COVID‐19 pandemic: Lessons from the first wave and implications for the future by Ragamin, Aviël, Wijs, Linde E. M., Hijnen, Dirk‐Jan, Arends, Nicolette J. T., Schuttelaar, Marie L. A., Pasmans, Suzanne G. M. A., Bronner, Madelon B.

Request full text

Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry by Bosma, Angela L., de Wijs, Linde E.M., Hof, Michel H., van Nieuwenhuizen, Beau R., Gerbens, Louise A.A., Middelkamp-Hup, Maritza A., Hijnen, DirkJan, Spuls, Phyllis I.

Get full text

Needs and preferences of patients regarding atopic dermatitis care in the era of new therapeutic options: a qualitative study by de Wijs, Linde E. M., van Egmond, Sven, Devillers, Arjan C. A., Nijsten, Tamar, Hijnen, DirkJan, Lugtenberg, Marjolein

Get full text

Effects of dupilumab treatment on patch test reactions: A retrospective evaluation by de Wijs, Linde E. M., van der Waa, José D., Nijsten, Tamar, Silverberg, Jonathan I., Kunkeler, Amalia C. M., Hijnen, Dirk J.

Get full text

Response to: “Comment on ‘Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, th... by Bosma, Angela L., de Wijs, Linde E.M., Hof, Michel H., van Nieuwenhuizen, Beau R., Gerbens, Louise A.A., Middelkamp-Hup, Maritza A., Hijnen, DirkJan, Spuls, Phyllis I.

Get full text

Adjusted dose regimens in dupilumab treatment for atopic dermatitis: Daily practice experiences by Olydam, Jill I., Wijs, Linde E. M., Nijsten, Tamar E. C., Rosmalen, Joost, Hijnen, Dirk Jan

Get full text